Medpace (MEDP)
(Delayed Data from NSDQ)
$405.68 USD
+4.49 (1.12%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $405.62 -0.06 (-0.01%) 5:24 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Medpace Holdings, Inc. [MEDP]
Reports for Purchase
Showing records 101 - 120 ( 124 total )
Company: Medpace Holdings, Inc.
Industry: Unclassified
Company: Medpace Holdings, Inc.
Industry: Unclassified
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Company: Medpace Holdings, Inc.
Industry: Unclassified
Initiating Coverage of Medpace Holdings with a Neutral Rating and $40 PT
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Medpace Holdings, Inc.
Industry: Unclassified
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Company: Medpace Holdings, Inc.
Industry: Unclassified
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Company: Medpace Holdings, Inc.
Industry: Unclassified
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Initial Take on 4Q17 Results and 2018 Guidance (Pre Conference Call)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Medpace Holdings, Inc.
Industry: Unclassified
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Company: Medpace Holdings, Inc.
Industry: Unclassified
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Initial Takeaways from 2Q17 Results (Pre-Conference Call)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Medpace Holdings, Inc.
Industry: Unclassified
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Medpace Holdings, Inc.
Industry: Unclassified
Company: Medpace Holdings, Inc.
Industry: Unclassified
Healthcare IT, Biopharmaceutical Services and Laboratories: Post-1Q17 Model Book
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Medpace Holdings, Inc.
Industry: Unclassified
Research Summary
Provider: KEYBANC CAPITAL MARKETS